Award notice Supplies

PNE 260028 - Implementation of a Frame Agreement - Acquisition of reagents for the existing lllumina Sequencing Platform

Public buyer: UNIVERSITE DU LUXEMBOURG
ESCH/BELVAL
Place of performance: ESCH/BELVAL
Amount awarded: €800,000 excl. VAT
Bids received: 1
Form: Framework agreement
Multi-year contract: the buyer places orders as needs arise.
Procedure: Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part.
Publication: 7 August 2026
Notice language: English

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

This order concerns the acquisition of sequencing reagents used on the dedicated lllumina sequencers operated by the Luxembourg Centre for Systems Biomedicine (LCSB) existing Sequencing Platform. This platform is part of the LCSB centrai facilities and provides next-generation sequencing services to the entire Luxembourg research community.

Awarded to

Illumina Netherlands BV

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33696500 33696300

Similar contracts already awarded

Contract	Winner	Amount
Centrale d'achat FHL: fourniture de médicaments divers (sous-groupes ATC L01 et L04). Fédération des Hôpitaux Luxembourgeois (FHL) · 3 August 2026	TAKEDA BELGIUM S.A. ABACUS Medicine A/S BIOGEN BELGIUM S.A.	€1
Centrale d'achat FHL: fourniture de produits de nutrition parentérale. Fédération des Hôpitaux Luxembourgeois (FHL) · 27 July 2026	Fresenius Kabi S.A. Baxter Belgium srl	€1,091,500

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 547805-2026.